Companies / Structure Therapeutics Inc.
Structure Therapeutics Inc.
Nasdaq: GPCRCIK 1888886SOUTH SAN FRANCISCO, CA
Financials
Ownership
213.9M shares outstanding · as of Jul 31, 2026
Ownership
| 10%+ / strategic | 20.31% | 43,447,980 |
| Institutions | 25.06% | 53,613,113 |
| Public float | 54.63% | 116,868,479 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 12
View all →| Insider | % of shares | Shares |
|---|---|---|
Berrios John JosephFormerChief Commercial Officer | — | — |
Coll Crespo BlasFormerCHIEF MEDICAL OFFICER | — | — |
Dobmeier EricDirector | — | — |
Fmr LLC10% owner | — | — |
Hall AshleyFormerChief Development Officer | — | — |
Lin XichenCHIEF SCIENTIFIC OFFICER | — | — |
Love Ted WDirector | — | — |
Ma YingliCHIEF TECHNOLOGY OFFICER | — | — |
Stevens Raymond CCEOCHIEF EXECUTIVE OFFICER · Director | — | — |
Tetlow SharonDirector | — | — |
Institutional holders 203
View all →| Holder | Value | % of shares |
|---|---|---|
| $605.94M | 4.07% | |
| $495.33M | 3.33% | |
| $455.94M | 3.06% | |
| $285.97M | 1.92% | |
| $258.26M | 2.50% | |
| $166.74M | 1.62% | |
| $145.21M | 0.98% | |
| $114.23M | 0.77% | |
| $84.53M | 0.82% | |
| $81.72M | 0.55% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Stevens Raymond C CEO | Other | Ordinary Shares | $1.12M | -53K -4.47% | 1,141,376 0.53% of shares | low |
| Mar 3, 2026 | Yoon Jun Executive | Other | Ordinary Shares | $468.2K | -22K -1.69% | 1,297,571 0.61% of shares | low |
| Mar 3, 2026 | Lin Xichen Executive | Other | Ordinary Shares | $393.2K | -19K -9.17% | 185,592 0.09% of shares | low |
| Mar 3, 2026 | Coll Crespo Blas Executive | Other | Ordinary Shares | $248.2K | -12K -5.45% | 204,981 0.10% of shares | low |
| Mar 3, 2026 | Ma Yingli Executive | Other | Ordinary Shares | $237.5K | -11K -9.53% | 107,391 0.05% of shares | low |
| Mar 3, 2026 | Hall Ashley Executive | Other | Ordinary Shares | $101.5K | -5K -4.31% | 107,481 0.05% of shares | low |
| Mar 19, 2026 | Coll Crespo Blas Executive | Grant | Ordinary Shares | $0 | +76K +37.03% | 280,878 0.13% of shares | low |
| Mar 19, 2026 | Ma Yingli Executive | Grant | Ordinary Shares | $0 | +33K +30.29% | 139,917 0.07% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Deep Track Capital, LP | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Wellington Management Group LLP | Passive13G/A | — |
| Biotechnology Value Fund L P | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| GPCR | ADR | 86366E106 |